New Technologies for Confident Decision-Making
With 100% endotoxin specificity, lot-to-lot consistency, and more streamlined workflows, our range of ENDONEXT™ solutions gives you confidence in your in-process control and product release decisions. Based on Recombinant Horseshoe Crab Factor C (rFC), ENDONEXT technology eliminates the need to harvest horseshoe crab blood and makes your laboratory more efficient, so you can optimize testing costs along the way.
ENDONEXT™ endotoxin detection assays are ushering in a new era of smarter, more sustainable pharmaceutical quality control.
The phenomenon of Low Endotoxin Recovery (LER) has gained renewed attention in the scientific community in recent years as the FDA now requires that all new Biological License Applications are able to successfully unmask when LER occurs. ENDOXPERTS™ is our solution for unmasking LER, which helps you meet regulatory requirements.
Laboratories don’t always need to test all 20 samples to fill a full plate—that’s why ENDOZYME® II GO STRIPS are designed with flexibility in mind: the flexibility to use only what you need, when you need it
A feasibility study is probably the single most important consideration when it comes to changing your method of application. Saving you time, resources, and energy, it’s a vital aspect of ensuring compatibility.